“…Multicomponent solid phases of active pharmaceutical ingredients (APIs) have become increasingly important in the drug-development process, primarily because they offer an alternative to the physical properties of neat API solid phases. , Co-crystals are a subset of these and are defined as crystalline materials in which two or more components are neutral molecules and solids at room temperature. , Previously referred to as binary compounds or complexes, co-crystals were first identified in the 19th century by melt crystallization. − Currently, solution crystallization is the preferred method for co-crystal formation, particularly to obtain single crystals for structure analysis. , However, its apparent failure in a number of cases , has led to the use of solid-state grinding and more recently, so-called “solvent drop” grinding techniques as alternatives to solution crystallization. − These latter, empirical process developments are not well-understood and their success has lent an air of mystery to the preparative methodology of co-crystal formation. Thus, for example, Shan et al reported on the preparation of a number of co-crystals of cyclohexan-1,3 cis ,5 cis -tricarboxylic acid by grinding and attempted to rationalize their results by invoking the concept of kinetic enhancements due to orientational and conformational freedom at interfaces, molecular collisions, and formation of tiny seed crystals resulting from solvent addition.…”